相关实验视频

Updated: Jul 4, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

从遗传性骨髓衰竭综合征/生殖线倾向综合征演变的骨髓质瘤:回到显微镜下

M Tarek Elghetany¹, Mrinal M Patnaik², Joseph D Khoury³

¹Department of Pathology & Immunology and Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.

Leukemia research

|February 1, 2024

概括

在遗传性骨髓衰竭综合征 (IBMFS) 中诊断骨髓瘤 (MDS) 具有挑战性,因为骨髓具有低细胞性和非典型细胞成熟. 为了在这些高风险患者中获得更好的结果,需要标准化的诊断标准.

科学领域:

血液学血液学血液学
在瘤学瘤学.
遗传学是一个遗传学.

背景情况:

遗传性骨髓衰竭综合征 (IBMFS) 和生殖线倾向综合征 (GPS) 增加了血液恶性瘤的风险,特别是骨髓瘤,如骨髓瘤 (MDS) 和急性骨髓白血病 (AML).
在IBMFS/GPS中,MDS诊断因骨髓低细胞性和影响细胞成熟的生殖系相关的失生性特征而复杂化.
在IBMFS/GPS患者中,MDS诊断往往表明预后较差.

研究的目的:

在IBMFS/GPS中审查MDS的诊断挑战.
突出了对标准化诊断标准和命名的需要.
建议一种更统一的方法来诊断MDS在这些特定的患者群体.

主要方法:

文献综述侧重于IBMFS/GPS中MDS的诊断标准.
对现有的形态学,细胞遗传学和遗传学标准的分析.
综合当前的挑战和建议的解决方案.

主要成果:

目前在IBMFS/GPS中MDS的诊断标准没有标准化.
骨髓低细胞性和生殖系诱导的失塑性特征使MDS诊断复杂化.
通常考虑的是形态学,细胞遗传学和遗传因素的组合.

结论:

标准化的诊断标准和命名对于在IBMFS/GPS中准确诊断MDS至关重要.
需要采用统一的方法来改善患者的治疗结果,并促进研究.
需要进一步的研究来完善在遗传综合征中MDS的诊断指南.

关键词:

骨髓骨髓骨髓骨髓骨髓细胞遗传学细胞遗传学发生在生殖线上的倾向性.遗传性骨髓衰竭遗传性骨髓衰竭骨髓质疏松症综合征的克隆演变.

更多相关视频

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Author Spotlight: Analyzing Bone Marrow Microenvironment in Murine Hematological Malignancies

Published on: November 10, 2023

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Lineage Commitment

Lineage Commitment

Commitment is the process whereby stem cells:

Mutations

Mutations

Cancers Originate from Somatic Mutations in a Single Cell

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...